Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, ...
from crm - BingNews https://ift.tt/3tQGCHI
May 14, 2021 at 09:09AM
No comments:
Post a Comment